Info@ThinkPinkRocks.com

Afatinib active against NSCLC nervous system metastases

Heavily pretreated patients with epidermal growth factor receptor-mutated non-small-cell lung cancer and central nervous system metastases may benefit from treatment with afatinib, say German researchers.

Read More:
Afatinib active against NSCLC nervous system metastases

Share

Leave a Reply

Solve : *
29 − 26 =